Issue |
J Extra Corpor Technol
Volume 54, Number 2, June 2022
|
|
---|---|---|
Page(s) | 142 - 147 | |
DOI | https://doi.org/10.1051/ject/202254142 | |
Published online | 15 June 2022 |
Technique Article
Nitric Oxide on Extracorporeal Life Support-Circuit Modifications for a Safe Therapy
* Cardiovascular Perfusion, Children’s of Alabama, Birmingham, Alabama;
† Congenital Heart Center, Shands Children’s Hospital, University of Florida, Gainesville, Florida;
‡ ECMO Department, Children’s of Alabama, Birmingham, Alabama;
§ Respiratory Therapy, Children’s of Alabama, Birmingham, Alabama; and
ǁ Section of Cardiac Critical Care, Division of Cardiology, Department of Pediatrics, the University of Alabama at Birmingham, Alabama
Address correspondence to: Carlisle O’Meara, CCP, FPP, Cardiovascular Perfusion, Children’s of Alabama, 1600 7th Ave S, Birmingham, AL 35233. E-mail: carlisle.omeara@childrensal.org
Received:
17
January
2022
Accepted:
14
May
2022
Nitric oxide (NO) incorporation into the sweep gas of the extracorporeal life support (ECLS) circuit has been proposed as a strategy to ameliorate the insults caused by the systemic inflammatory response. This technical study describes circuit modifications allowing nitric oxide to be incorporated into the circuit and describing and validating the oxygenator sweep flow rates necessary to achieve consistent safe delivery of the therapy. For patients requiring sweep rates less than 2 L/min, a simplified setup, incorporating a pressure relief valve/low flow meter in the gas delivery line, was placed in line between the blender/NO injector module and the NO sampling port/oxygenator. This setup allows titration of sweep to low flows without the need to blend in CO2 while maintaining the manufacturer recommendation of a minimum 2 L/min of sweep gas to safely deliver NO without nitric dioxide (NO2) buildup. This setup was tested three times at three different FiO2 rates and eleven different desired low sweep flows to test for reproducibility and safety to build an easy-to-follow chart for making gas flow changes. For patients requiring oxygenator sweep rates greater than 2 L/min, the pressure relief valve/low flow meter apparatus is not needed. Maintaining consistent sweep rate and nitric oxide delivery is required in order to utilize this therapy in ECLS. We demonstrated gas delivery across all flow rates. There were no issues delivering 20 parts per million of NO and negligible NO2 detection. The results from testing this setup were used to provide the specialist a chart at which to set the low flow meter to produce the desired flow rate at which the patient needs. This has been used clinically on 15 ECLS patients with success.
Key words: extracorporeal life support / extracorporeal membrane oxygenation / nitric oxide / thrombosis / platelet activation / inflammation / circuit modification / pressure relief valve.
© 2022 AMSECT
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.